Dec. 8, 2025—Randox’s type 1 diabetes risk test has received CE marking. The Type 1 Diabetes Genetic Risk Score array, developed in partnership with the University of Exeter, provides a genetic risk score based on up to 10 diabetes-associated variants, identifying people at greatest risk before autoantibodies develop or symptoms emerge. Individuals with elevated scores can then be referred for confirmatory antibody testing and monitoring. The TD1 biochip can also support clinical decision-making after diagnosis by helping distinguish type 1 from type 2 diabetes.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY